So far, the adverse events have been reported for the 2 fluid-filled designs, not for an air-filed design later approved.
The FDA has alerted healthcare providers about reports of adverse events from the fluid-filled balloons approved over the past 2 years to treat obesity.
The FDA’s February 9, 2016, notice reports 2 types of events:
In 2015, the FDA approved 2 fluid-filled balloon systems, the ReShape integrated dual balloon system, and the Orbera balloon system. ReShape uses 2 balloons, while Orbera uses 1 balloon. Both systems place the balloons into the stomach through the mouth, using an endoscopic procedure.
In 2016, the FDA has also approved the Obalon system, which uses a swallowable capsule to place up to 3 balloons. The capsule is attached to a catheter used to fill the balloons with air. So far, the FDA, reports, the adverse events reported have not affected this balloon system.
The FDA reminds providers to report any adverse reactions through its MedWatch system, which can be found here.
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More